Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…
USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…
Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
Alexion announced plans to initiate phase 3 study of ULTOMIRISﾮ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISﾮ (ravulizumab-cwvz)…
Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…
IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
Rice University COVID-19 research fund awarded first grants
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…
CDC | COVID-19 | Life Science History | NIH
The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
Five Oxford University COVID-19 projects received UK Research and Innovation funding
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
Roche developed new serology test to detect COVID-19 antibodies
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
Pulmatrix and Sensory Cloud announced partnership to develop and commercialize nasal prophylactic and anticontagion product for COVID-19
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
CHF Solutions announced 300% increase in utilization of Aquadex Therapy in NYC hospitals, the epicenter of COVID-19
On Apr. 16, 2020, CHF Solutions announced increased utilization of its Aquadex therapy in patients affected by COVID-19….
Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
Abbott launched third COVID-19 test, a laboratory-based antibody blood test
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…